Cite
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio.
MLA
Zhang, Wei, et al. “Predicting Worse Survival for Newly Diagnosed T Cell Lymphoma Based on the Decreased Baseline CD16−/CD16 + Monocyte Ratio.” Scientific Reports, vol. 10, no. 1, May 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41598-020-64579-z.
APA
Zhang, W., Ruan, J., Zhou, D., Han, X., Zhang, Y., Wang, W., & Ouyang, M. (2020). Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio. Scientific Reports, 10(1), 1–9. https://doi.org/10.1038/s41598-020-64579-z
Chicago
Zhang, Wei, Jing Ruan, Daobin Zhou, Xiao Han, Yan Zhang, Wei Wang, and Mingqi Ouyang. 2020. “Predicting Worse Survival for Newly Diagnosed T Cell Lymphoma Based on the Decreased Baseline CD16−/CD16 + Monocyte Ratio.” Scientific Reports 10 (1): 1–9. doi:10.1038/s41598-020-64579-z.